Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Wu
    Wu
  10. Wolden
    Wolden

Groups

  1. Department of Medicine (4610)
  2. Surgery (3546)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2158)
  6. GSK Faculty (1937)
  7. Center for Hematologic Malignancies (1674)
  8. Hematologic Malignancies, Division of (1609)
  9. Gynecology Disease Management Team (1425)
  10. Sloan Kettering Institute Faculty (1413)
Search Within
Formats
  1. Journal Article (7387)
  2. Meeting Abstract (4694)
  3. Review (616)
  4. Book Section (538)
  5. Editorial (250)
  6. Conference Paper (138)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4610)
  2. Surgery (3546)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2158)
  6. GSK Faculty (1937)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (377)

More People

Years
  1. 2025 (240)
  2. 2024 (784)
  3. 2023 (762)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2610)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (967)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (524)
  6. Journal of Sexual Medicine (435)

More Publications

Results (13855)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes by age with neoadjuvant atezolizumab treatment for resectable non-small cell lung cancer in the phase 2 LCMC3 study
    Meeting Abstract

    Presley, C.; Owen, D. H.; Nicholas, A.; Hilz, S.; Oezkan, F.; Chaft, J. E.; Toloza, E. M.; Haura, E. B.; Patterson, A.; Waqar, S. N.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • The paradoxical behavior of Kappa when quantifying agreement in histological subtype classification among thoracic pathologists
    Meeting Abstract

    Tan, K. S.; Adusumilli, P.; Travis, W. D.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Factors associated with disease progression after discontinuation of immunotherapy for immune-related toxicity in non-small cell lung cancer
    Meeting Abstract

    Pecci, F.; Thummalapalli, R.; Alden, S.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Rizvi, H.; Wang, X.; Egger, J. V.; Vaz, V. R.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with EGFR-mutant lung cancer with acquired BRAF alterations
    Meeting Abstract

    Sui, J.; Yang, S. R.; Bowman, A. S.; Vankayala, P.; Falcon, C.; Somwar, R.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • The IASLC pleural mesothelioma staging project: Updated modeling of prognostic factors in pleural mesothelioma
    Meeting Abstract

    Wolf, A. S.; Rosenthal, A.; Giroux, D. J.; Nowak, A. K.; Bille, A.; de Perrot, M.; Kindler, H. L.; Rice, D.; Opitz, I.; Rusch, V. W.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Consolidation EGFR-tyrosine kinase inhibitor (TKI)vs. durvalumab vs. observation in unresectable EGFR-mutant stage III NSCLC
    Meeting Abstract

    Nassar, A. H.; Adib, E.; Kaldas, D.; Feng, J.; AbuAli, T.; Aredo, J.; Fitzgerald, B.; Bar, J.; Thummalapalli, R.; Parikh, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Predictive biomarkers of response to REGN5093 to guide patient selection in MET-altered advanced non-small cell lung cancer
    Meeting Abstract

    Navas, T.; Drilon, A. E.; Cho, B. C.; Viau, J.; Tao, W.; Zhu, Y. O.; Giangreco, N.; Perez, J.; Masinde, S.; Paccaly, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 multicohort study of CC-90011, a LSD1 inhibitor, in combination with nivolumab in patients with advanced lung cancer
    Meeting Abstract

    Rudin, C. M.; Navarro, A.; Carcereny, E.; Villaruz, L. C.; Lo Russo, G.; Ricordel, C.; Bearz, A.; Li, J.; Elias, I.; Bhingare, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Microsatellite instability defines a subset of lung cancers with smoking exposure, high tumor mutational burden and MLH1 inactivation
    Meeting Abstract

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benhamida, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save